|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 14/605 | |
| C07K 14/575 | |||
| C07K 14/62 | |||
| A61K 38/26 | |||
| A61K 38/22 | |||
| A61P 3/10 |
| (11) | Patento numeris | 2590997 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11804451.0 |
| Europos patento paraiškos padavimo data | 2011-07-08 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-05-15 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-04-04 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2011/043465 |
| Data | 2011-07-08 |
| (87) | Numeris | WO 2012/006598 |
| Data | 2012-01-12 |
| (30) | Numeris | Data | Šalis |
| 363097 P | 2010-07-09 | US |
| (72) |
WALENSKY, Loren, D., US
BIRD, Gregory, US
|
| (73) |
Dana-Farber Cancer Institute, Inc.,
450 Brookline Avenue, Boston, MA 02215,
US
|
| (54) | STABILIZED INSULINOTROPIC PEPTIDES AND METHODS OF USE |
| STABILIZED INSULINOTROPIC PEPTIDES AND METHODS OF USE |